​

Viatris (VTRS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

VTRS Stock Forecast

Viatris (VTRS) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $15.50, with a high of $16.00 and a low of $15.00. This represents a 17.34% increase from the last price of $13.21.

$10 $11 $12 $13 $14 $15 $16 High: $16 Avg: $15.5 Low: $15 Last Closed Price: $13.21

VTRS Stock Rating

Viatris stock's rating consensus is Hold, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (16.67%), 8 Hold (66.67%), 2 Sell (16.67%), and 0 Strong Sell (0.00%).

Hold
Total 12 0 2 8 2 Strong Sell Sell Hold Buy Strong Buy

VTRS Price Target Upside V Benchmarks

TypeNameUpside
StockViatris17.34%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks18.29%

Price Target Trends

1M3M12M
# Anlaysts223
Avg Price Target$15.50$15.50$15.33
Last Closing Price$13.21$13.21$13.21
Upside/Downside17.34%17.34%16.05%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26136-111
Dec, 25-36-110
Nov, 25135-110
Oct, 25125-19
Sep, 25125-19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 16, 2026Argus Research$15.00$12.8416.82%13.55%
Jan 07, 2026Les SulewskiTruist Financial$16.00$12.4029.03%21.12%
Oct 15, 2025Truist Financial$15.00$9.9351.06%13.55%
Jul 19, 2024Glen SantangeloJefferies$15.00$11.7727.44%13.55%
Mar 28, 2024David AmsellemPiper Sandler$13.00$11.839.89%-1.59%
Jun 26, 2023David AmsellemPiper Sandler$10.00$9.841.63%-24.30%
Feb 01, 2023Barclays$15.00$12.1623.36%13.55%
Nov 09, 2022Ashwani VermaUBS$12.00$10.8310.80%-9.16%
Jun 13, 2022Ashwani VermaUBS$9.00$10.77-16.43%-31.87%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 08, 2025BarclaysUnderweightOverweightinitialise
Mar 07, 2025JefferiesBuyBuyhold
Mar 05, 2025Piper SandlerNeutralNeutralhold
Mar 28, 2024Piper SandlerNeutralNeutralhold
Jan 12, 2024Cowen & Co.Market Performdowngrade
Dec 27, 2023Morgan StanleyEqual-WeightEqual-Weighthold
Sep 27, 2023Wells FargoEqual-WeightEqual-Weighthold
Jun 26, 2023BMO CapitalPerformMarket Performdowngrade
Feb 17, 2023BMO CapitalMarket PerformPerformdowngrade
Feb 17, 2023BMO CapitalMarket Performdowngrade

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 $4 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-1.05$1.71$0.05$-0.53---
Avg Forecast$3.72$3.39$2.96$2.68$2.63$2.69$2.58
High Forecast$3.81$3.42$3.00$2.71$2.75$3.70$2.63
Low Forecast$3.66$3.36$2.90$2.65$2.51$1.57$2.49
Surprise %-128.23%-49.56%-98.31%-119.78%---

Revenue Forecast

$14B $15B $16B $17B $18B $19B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$17.89B$16.26B$15.43B$14.74B---
Avg Forecast$17.89B$16.37B$15.47B$14.81B$14.29B$14.35B$16.56B
High Forecast$18.23B$16.45B$15.53B$14.86B$14.52B$14.38B$16.80B
Low Forecast$17.67B$16.24B$15.42B$14.70B$13.95B$14.32B$16.13B
Surprise %-0.01%-0.67%-0.30%-0.49%---

Net Income Forecast

$-2B $-300M $900M $2B $3B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-1.27B$2.08B$54.70M$-634.20M---
Avg Forecast$-1.13B$66.99M$54.70M$3.24B$3.17B$3.18B$3.09B
High Forecast$-795.14M$309.54M$252.76M$3.27B$3.32B$4.46B$3.17B
Low Forecast$-1.47B$-175.56M$-143.36M$3.20B$3.02B$1.90B$3.01B
Surprise %12.29%3002.87%--119.59%---

VTRS Forecast FAQ

Is Viatris stock a buy?

Viatris stock has a consensus rating of Hold, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 8 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Viatris is a neutral investment for most analysts.

What is Viatris's price target?

Viatris's price target, set by 12 Wall Street analysts, averages $15.5 over the next 12 months. The price target range spans from $15 at the low end to $16 at the high end, suggesting a potential 17.34% change from the previous closing price of $13.21.

How does Viatris stock forecast compare to its benchmarks?

Viatris's stock forecast shows a 17.34% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (18.29%).

What is the breakdown of analyst ratings for Viatris over the past three months?

  • January 2026: 9.09% Strong Buy, 27.27% Buy, 54.55% Hold, 0% Sell, 9.09% Strong Sell.
  • December 2025: 0% Strong Buy, 30.00% Buy, 60.00% Hold, 0% Sell, 10.00% Strong Sell.
  • November 2025: 10.00% Strong Buy, 30.00% Buy, 50.00% Hold, 0% Sell, 10.00% Strong Sell.

What is Viatris’s EPS forecast?

Viatris's average annual EPS forecast for its fiscal year ending in December 2025 is $2.63, marking a -596.23% decrease from the reported $-0.53 in 2024. Estimates for the following years are $2.69 in 2026, and $2.58 in 2027.

What is Viatris’s revenue forecast?

Viatris's average annual revenue forecast for its fiscal year ending in December 2025 is $14.29B, reflecting a -3.05% decrease from the reported $14.74B in 2024. The forecast for 2026 is $14.35B, and $16.56B for 2027.

What is Viatris’s net income forecast?

Viatris's net income forecast for the fiscal year ending in December 2025 stands at $3.17B, representing a -600.11% decrease from the reported $-634M in 2024. Projections indicate $3.18B in 2026, and $3.09B in 2027.